Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.82 |
| ▸ | CA1 | P00915 | 6/20 | 0.82 |
| ▸ | PPARA | Q07869 | 4/20 | 0.78 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 2/20 | 0.52 |
| ▸ | CA7 | P43166 | 2/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.52 |
| ▸ | RELA | Q04206 | 4/20 | 0.49 |
| ▸ | CA9 | Q16790 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3108251 | 1.00 | CA2 (0.82) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL1668208 | 1.00 | CA2 (0.82) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL3787723 | 1.00 | CA2 (0.82) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL3794668 | 1.00 | CA2 (0.82) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL291897 | 1.00 | CA2 (0.82) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL1228645 | 1.00 | CA2 (0.82) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL4622863 | 1.00 | CA2 (0.82) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL3792229 | 1.00 | CA2 (0.82) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL3124345 | 1.00 | CA2 (0.82) | CA2CA1PPARAEPHX1CA12 | |
| Fluoride SCHEMBL28507310 | 0.98 | CA2 (0.78) | CA2CA1PPARAEPHX1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110591214-B | Fluorine-containing organic montmorillonite modified EVA (ethylene-vinyl acetate) foam material and preparation method thereof | 泉州师范学院 | 2022-03-11 | — | — | CN | claimed |
| CN-107163926-B | Sand control method for artificial well wall and sand control material thereof | 东营市科诺石油技术有限责任公司 | 2020-07-07 | — | — | CN | claimed |
| CN-107523015-B | Preparation method of carbon nano tube-montmorillonite self-assembly nano powder grafted glass fiber reinforced resin composite material | 河海大学 | 2020-02-18 | — | — | CN | claimed |
| CN-110591214-A | Fluorine-containing organic montmorillonite modified EVA (ethylene-vinyl acetate) foam material and preparation method thereof | 泉州师范学院 | 2019-12-20 | — | — | CN | claimed |
| US-20250186409-A1 | 5-AMINOHEXAHYDRO-6,7,8-TRIHYDROXY-3H-OXAZOLO[3,4-A]PYRIDIN-3-ONE DERIVATIVES DERIVATIVES AS TLR4 MODULATORS FOR THE TREATMENT OF IMMUNE DISEASES | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) | 2025-06-12 | — | — | US | disclosed |
| EP-4423092-A1 | 5-AMINOHEXAHYDRO-6,7,8-TRIHYDROXY-3H-OXAZOLO[3,4-A]PYRIDIN-3-ONE DERIVATIVES DERIVATIVES AS TLR4 MODULATORS FOR THE TREATMENT OF IMMUNE DISEASES | Consejo Superior de Investigaciones Científicas (CSIC) (ES) | 2024-09-04 | — | — | EP | disclosed |
| US-11993697-B2 | Flexible tube for endoscope, endoscopic medical device, and resin composition for covering flexible tube substrate for endoscope | FUJIFILM CORPORATION (JP) | 2024-05-28 | — | — | US | disclosed |
| WO-2024085171-A1 | LIGHT ABSORPTION FILTER, OPTICAL FILTER AND METHOD FOR PRODUCING SAME, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, INORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE | 富士フイルム株式会社 | 2024-04-25 | — | — | WO | disclosed |
| WO-2024085172-A1 | LIGHT ABSORPTION FILTER, OPTICAL FILTER AND METHOD FOR PRODUCING SAME, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, INORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE | 富士フイルム株式会社 | 2024-04-25 | — | — | WO | disclosed |
| US-11958959-B2 | Lens for spectacles and spectacles | FUJIFILM CORPORATION (JP) | 2024-04-16 | — | — | US | disclosed |
| US-20240084106-A1 | KNEADED MATERIAL, METHOD OF PRODUCING KNEADED MATERIAL, MOLDED BODY, AND OPTICAL MEMBER | FUJIFILM CORPORATION (JP) | 2024-03-14 | — | — | US | disclosed |
| EP-3646770-B1 | ENDOSCOPE FLEXIBLE TUBE, ENDOSCOPE-TYPE MEDICAL DEVICE, RESIN COMPOSITION FOR COATING ENDOSCOPE FLEXIBLE-TUBE SUBSTRATE, AND RESIN COMPOSITION SET FOR COATING ENDOSCOPE FLEXIBLE-TUBE SUBSTRATE | FUJIFILM CORP (JP) | 2024-03-13 | — | — | EP | disclosed |
| US-5006453-A | With specific oil soluble coupler, solvent, polymer having no acid groups | FUJI PHOTO FILM CO. LTD. (JP) | 1991-04-09 | — | — | US | disclosed |
| US-4962014-A | USING SULFITE CONTAINING BLIXING LIQUID TO SHORTEN TIME AND REDUCE WATER CONSUMPTION WITHOUT IMPAIRING STORAGE STABILITY | FUJI PHOTO FILM CO., LTD. (JP) | 1990-10-09 | — | — | US | disclosed |
| US-4914007-A | REDUCING THE WATER WASHING TIME OF CONTINUOUS COLOR DEVELOPMENT | FUJI PHOTO FILM CO., LTD. (JP) | 1990-04-03 | — | — | US | disclosed |
| EP-0304067-A2 | Silver halide color photographic light-sensitive material containing epoxy compound | Fuji Photo Film Co., Ltd. (JP) | 1989-02-22 | — | — | EP | disclosed |
| EP-0276319-A1 | SILVER HALIDE COLOR PHOTOGRAPHIC MATERIAL | FUJI PHOTO FILM CO., LTD. (JP) | 1988-08-03 | — | — | EP | disclosed |
| US-4588677-A | 4-MERCAPTO-5-PYRAZOLONE TYPE MAGENTA COUPLERS | FUJI PHOTO FILM CO., LTD. (JP) | 1986-05-13 | — | — | US | disclosed |
| US-4584266-A | 2-EQUIVALENT 5-PYRAZOLONE MAGENTA COUPLER | FUJI PHOTO FILM CO., LTD. (JP) | 1986-04-22 | — | — | US | disclosed |
| US-4556630-A | NOVEL MAGENTA COUPLERS HAVING ARYLTHIO GROUP AT THE COUPLING ACTIVE POSITION OF A PYRAZOLONE | FUJI PHOTO FILM CO., LTD. (JP) | 1985-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250186409-A1 | 5-AMINOHEXAHYDRO-6,7,8-TRIHYDROXY-3H-OXAZOLO[3,4-A]PYRIDIN-3-ONE DERIVATIVES DERIVATIVES AS TLR4 MODULATORS FOR THE TREATMENT OF IMMUNE DISEASES | TLR1, TLR4, TLR6 | CA2 4820/4885CA1 4840/4885PPARA 713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.